- On Announcement of All Oral MDR TB regimen by Indian Government
- Modi visit to US: Trump appearance signals importance of India
- After ‘Howdy Modi’, Trump and Modi likely to sign trade deal
- US – India Relations: President Trump To Sign New Trade Deal With Indian PM Modi?
- India-US trade talks: Trading lives?
Category Archives: Novartis Case
Source: Statnews 27th May, 2019 The Food and Drug Administration on Friday approved the first gene therapy for a type of spinal muscular atrophy, a lifesaving treatment for infants that will also be the most expensive drug in the world. … Continue reading
Source: Intellectual Property Watch | May 21, 2018 On 1 April 2013, in a packed room inside India’s Supreme Court, a magnificent building in Indo-British architectural style, two judges delivered a verdict that impacted the national and global conversation about … Continue reading
Global protests ahead of Novartis AGM in Switzerland tomorrow Call for new CEO to clean up company following scandals in Colombia and Greece Thursday 1 March 2018 – Swiss multinational Novartis today faced international calls from an alliance of health … Continue reading
Anne Aerts, head of Novartis Foundation, addresses a conference in Basel, Switzerland, looking at the role of drug companies in building health systems. (Credit: Kiara Barnes/Novartis) BASEL, Switzerland — The controversial Swiss pharmaceutical company Novartis has started work to expand … Continue reading
As US Trade Representative Arrives in Delhi, MSF Urges India to Stand Strong Against Attack on Affordable Medicines
Source: MSF Access Campaign New Delhi, 25 November 2014—As US Trade Representative Michael Froman meets high-ranking Indian officials to likely pressure the government to weaken its pro-public health patent law, Doctors Without Borders/ Médecins Sans Frontières (MSF) urged the new … Continue reading
Source: TWN Geneva, 11 Nov (Kanaga Raja) — The South Centre has expressed concern over the pressures being placed on India by the United States Trade Representative (USTR) through the out-of-cycle review of the country’s intellectual property (IP) laws and … Continue reading
Source: Business Standard The Commerce and Industry Ministry is looking into the merit of Cipla’s demand for revocation of patents of Swiss drug major Novartis for respiratory drug Indacaterol citing the need for public health access. The Department of Industrial … Continue reading